Αρχική ACTIVE PARTICIPATION IN CONFERENCES

ACTIVE PARTICIPATION IN CONFERENCES

Conferences

  • European Society of Neuroscience, 1994
  • Society for Neuroscience, 1995
  • 23rd Goetingen Neurobiology Conference.
  • MR Screening in Women at High Genetic Risk of Breast Cancer. Current and Planned Studies, International Collaboration and Combined Analysis
  • 22nd International Breast Cancer Research Congress of the IABCR
  • 9th Panhellenic Congress of Clinical Oncology, April 2000. Our work was awarded the first prize*.
  • European School of Oncology, Athens 1999.
  • European School of Oncology, Kos 2000.
  • HeCG meetings every four months during 2000*.
  • European Association of Cancer Research, XVI EACR Congress, 2000.
  • European School of Oncology, Thessaloniki 2000.
  • HeCΟG Meeting, October 2000*.
  • European Association of Medical Oncology, 25th ESMO Congress, 2000.
  • Association of Biomedical Technology of Crete, November, 2000*.
  • 10th Panhellenic Congress of Clinical Oncology, April 2001*.
  • Series of lectures invited by the German Federal Minister of Health, Duesseldorf, June 2001*.
  • Biotechnology Meeting, Mykonos, July 2001*.
  • HeCG meetings every four months during 2001*.
  • Association of Biomedical Technology of Crete, November, 2001*.
  • HPV and EBV infection and their relation to apoptosis and angiogenesis related proteins in operable laryngeal carcinomas, ESMO, October 2002.
  • Detection of HER 1, HER 2, HER 3 and HER 4 in patients receiving Taxol+Carboplatin+Iressa with advanced breast cancer, HECOG, June 2002.
  • Infection with EBV and HPV viruses and their relationship to proteins involved in apoptosis and angiogenesis in surgically resectable laryngeal cancer, HECOG, June 2002*.
  • The prognostic role of proteins involved in apoptosis and angiogenesis in patients with high-risk resectable rectal and colorectal cancer following chemotherapy treatment with FU/LEUCOVORIN according to HECOG protocols: He 6c/91, He 6d/91 He 6d/98, He 6d/99, He 6c/98, He 6c/99, He 6e/99, HECOG, June 2002.
  • The prognostic role of TP and TS proteins in patients with high-risk resectable rectal and colorectal cancer following chemotherapy treatment with FU/LEUCOVORIN according to HECOG protocols: He 6c/91, He 6d/91, He 6d/98, , He 6d/99, He 6c/98, He 6c/99, He 6e/99, HECOG, June 2002.
  • From idea to OBI and PCT process, Crete May 2002*.
  • Targeting HER-2 and EGFR, HAPSc, August 2002*.
  • The contribution of molecular techniques to the determination of prognosis, HAPSc, September 2002*.
  • Detection of Ep-Cam antigen in patients with metastatic breast cancer, HECOG, October 02.*
  • The contribution of translational research to the establishment of new prognostic and predictive factors in breast cancer, HECOG, October 02*.
  • Infection with EBV and HPV viruses and their relationship to proteins involved in apoptosis and angiogenesis in surgically resectable laryngeal cancer, 10th Postgraduate Seminar of Clinical Oncology, Crete, November 2002*.
  • Detection of mRNA CK-19 and Ep-Cam antigen and micrometastatic cancer cells in patients with resectable node-positive breast cancer receiving E-T-CMF vs ET-CMF chemotherapy, 10th Postgraduate Seminar of Clinical Oncology, Crete, November 2002*.
  • Molecular diagnostics and cancer. New approach to detecting residual disease. A new PCR product detection system, Panhellenic Congress of Clinical Chemistry, Athens, November 2002*.
  • Use of metabolomic techniques for the detection of disturbances in digestion, absorption and to identify how affect the cellular procedures, educative seminar, October 2010, by Lamberts. S.A., Greece*.
  • Seminars in Nutritionists for interpretation of metabolomics results, 2011 & 2012*.
  • What is precision medicine, techniques used for results interpretation and how supplements can be used in daily praxis, Symmetria S.A., 2022*
  • Antiaging and Skin, Sothys S.A. Greece, 2024*
  • The Princip of Whole. Hippocratic Week, Kos 2024*.

Ομιλίες

Presentations in Conference
Georgakopoulos E., Gass P., Schmid W., Kiessling M., Bravo R., Zimmerman M and Herdegen T (1994)*: «Phosphorylation of CREB and SRF, and expression of CREM, Jun, Fos and Krox transcription factors in the rat brain following seizure activity». European Journal of Neuroscience, Suppl. 7: 45.08.

Herdegen T., Gass P., Brecht T., Schmid W., Georgakopoulos E., Hajek I., Bravo R. and Zimmermann M. (1994): «Transection of central and peripheral nerve fibers selectively effects the expression and phosphorylation of CREB, CREM and SRF proteins in axotomised neurons». European Journal of Neuroscience, Suppl. 7: 119.05.

Herdegen T., Georgakopoulos E., Brecht T., Schmid W., Bravo R and Gess P. (1994)*: «Expression and activation of CREB, CREM ATF,SRF and Jun, Fos transcription factors: key events for selective control of gene induction in the nervous system». Abstracts of the Society for Neuroscience, 20: 270.7.

Georgakopoulos E., Blume A., Gas P., Zimmermann M and Herdegen T. (1995): «Phosphorylation of CREB and SRF, expression of Jun, Fos and Krox proteins and activation of the c-jun promotor following generalised seizures». Proccedings of the 23rd Goetingen Neurobiology Conference.

Georgakopoulos E., Kapridaki E., Papageorgiou G., Georgakopoulou S and Garas I. (1998)*: «BRCA1 Mutations in Hereditary Breast Cancer in Greek Population». Proceedings of MR Screening in Women at High Genetic Risk of Breast Cancer. Current and Planned Studies, International Collaboration and Combined Analysis

E. Georgakopoulos*, C. Christodoulou, G. Klouvas, S. Georgakopoulou, G. Vogiatzis and D. Skarlos: “Detection of mRNA antigen 17-1A in peripheral blood of patients with hormone-resistant prostate cancer”, 9th Panhellenic Congress of Clinical Oncology, April 2000. The paper was awarded the first prize.

E. Georgakopoulos*, C. Christodoulou, G. Klouvas, S. Georgakopoulou, G.Bogiatzis and D.Skarlos: «Detection of the 17-1A Antigen mRNA in Circulating Blood and the Efficacy of the Monoclonal Antibody Enderocolomab in Patients with Hormone Prostate Cancer», European Association of Cancer Research, XVI EACR Congress, 2000

E. Georgakopoulos*, C. Christodoulou, G. Klouvas, S. Georgakopoulou, G.Bogiatzis and D.Skarlos: « Detection of the 17-1A Antigen mRNA in Circulating Blood and the Efficacy of the Monoclonal Antibody Enderocolomab in Patients with Hormone Prostate Cancer (preliminary results)», European Association of Medical Oncology, 25th ESMO Congress, Vol.11, 2000.

S.Papandreou, S. Georgakopoulou, E. Goga, D Skarlos, G. Fountzilas and E. Georgakopoulos: «Molecular detection of micrometastasis and circulated cancer cells in positive node patients with breast cancer treated with E-T-CMF versus ET-CMF as adjuvant chemotherapy», Association of Biomedical Technology of Crete, November, 2000.

E. Georgakopoulos:* “Molecular Biology: Realism and Expectations”, 10th Panhellenic Congress of Clinical Oncology, April 2001.

E. Georgakopoulos:* “Molecular Biology and Cancer”, Lecture invited by the German Federal Minister of Health, Duesseldorf, June 2001.

Georgakopoulos E.*: «Biotechnology in Greece», Biotechnology Meeting, Mykonos,
July‘01.

E. Georgakopoulos:* “The contribution of molecular techniques to the determination of prognosis”, HAPSc, September 2002

E. Georgakopoulos:* “The contribution of translational research to the establishment of new prognostic and predictive factors in breast cancer”, HECOG, October 2002.

K. Vlachtsis*, C. Karanikiotes, E. Georgakopoulos, S. Georgakopoulou, S. Papandreou, J. Daniilidis, G. Fountzilas: «HPV and EBV infection and their relation to apoptosis and angiogenesis related proteins in operable laryngeal carcinomas», ESMO, Poster symposiumLung and head and neck cancers 1: b) Prognostic factors and biological therapies Sunday, 20 October 2002

S. Papandreou, S. Georgakopoulou, C. Karanikiotis, G. Fountzilas and E. Georgakopoulos:* “Detection of mRNA CK-19 and Ep-Cam antigen and micrometastatic cancer cells in patients with resectable breast cancer with positive lymph nodes receiving chemotherapy E-T-CMF vs ET-CMF” 10th Postgraduate Seminar of Clinical Oncology, Crete, November 2002.

E. Georgakopoulos:* “Molecular diagnostics and cancer. New approach to detecting residual disease. A new PCR product detection system”, Panhellenic Congress of Clinical Chemistry, Athens, November 2002.

C. Karanikiotis*, K. Vlahtsis, S. Georgakopoulou, S. Papandreou, S. Gerou, and E. Georgakopoulos: “Detection of the genome of the EPSTEIN – BARR virus in the peripheral blood of healthy people and its correlation with serum antibody levels” 12th Armed Forces Congress, Thessaloniki, November 2002.

*: Presented as a lecture

8